Previous Article | Next Article ![]()
Journal of Virology, June 1999, p. 4919-4924, Vol. 73, No. 6
Department of Molecular Microbiology and
Immunology, Johns Hopkins School of Public Health, Baltimore,
Maryland 21205
Received 22 December 1998/Accepted 16 March 1999
The alphavirus Sindbis virus (SV) has a wide host range and infects
many types of cultured cells in vitro. The outcome of infection is
dependent on the strain of virus used for infection and the properties
of the cells infected. To identify cellular determinants of
susceptibility to SV infection we mutagenized Chinese hamster ovary
(CHO) cells by retroviral insertion with a vector containing the
neomycin resistance gene that allowed selection for integration into
transcriptionally active genes. Cells were then selected for survival
after infection with SV. The most resistant cell line (CHO-18.4m)
exhibited delayed virus replication and virus-induced cell death, had a
single retroviral insertion, and was defective in SV binding to the
cell surface. Further analysis revealed that CHO-18.4m cells were
deficient in the expression of the sulfated glycosaminoglycans heparan
sulfate and chondroitin sulfate. This further confirms the importance of heparan sulfate as an attachment molecule for SV in vitro and demonstrates the usefulness of this technique for identifying cellular
genes that are important for virus replication.
Sindbis virus (SV) is an enveloped,
message-sense, single-strand RNA virus that causes rash and arthritis
in humans (30) and encephalomyelitis in mice
(18). In mice the primary target cells for SV infection are
neurons in the brain and spinal cord, and the outcome of central
nervous system infection is linked to the efficiency of virus
replication and the induction of apoptosis in these cells (19,
24). Newborn mice are very susceptible to fatal SV-induced
encephalomyelitis, while in older mice infection is less likely to be
fatal. This is linked to the susceptibility of immature neurons to
SV-induced apoptosis, while mature neurons often survive infection
(23, 24). However, the cellular and host factors responsible
for these differences in outcome are largely unknown.
SV has two surface glycoproteins, E1 and E2, which form heterodimers
that are trimerized into spikes on the virion surface (36).
E2 is an important determinant of virulence and plays a role in the
initial binding of the virus to the cell surface. SV, like all
alphaviruses, has a wide host range, and the natural cycle of infection
requires replication in both vertebrate and invertebrate hosts. Host
factors are required not only for virus binding and entry, but also for
the replication of plus- and minus-strand RNA, the transcription
and translation of mRNA, and the synthesis and processing of the
glycoproteins. Thus, there are many steps in the virus life cycle where
differences in the availability or specificity of host cell factors
could affect virus replication. In addition, the susceptibility of a
cell to the induction of apoptosis by SV infection is dependent on the
expression of an array of apoptotic and antiapoptotic factors that are
still incompletely defined (11).
To begin to identify cellular factors that influence the outcome of SV
infection we have used a retroviral gene trap strategy that
incorporates the use of a selectable marker to enrich for cells with
insertional mutations (6, 42) to generate mutant Chinese
hamster ovary (CHO) cells resistant to SV. CHO cells were chosen for
this study because they are hypodiploid and have substantial functional
hemizygosity at many different loci (14, 15), and mutants
have been isolated from CHO cells at a frequency representing genes
with a single allele (35), including cells with resistance to SV infection (27, 28). Therefore, CHO cells appear to be a cell line appropriate for genetic mutant isolation by using retroviruses as insertional mutagens. The gene trap approach has been
successfully employed for mutagenesis in vitro and in vivo, and the
retrovirus can serve as a useful tag for the identification of the
disrupted gene (9, 16, 21).
In this study a number of mutant CHO cell clones partially resistant to
SV infection were generated. One of these cell lines, CHO-18.4m, had a
single retroviral insertion and was highly resistant to SV-induced cell
death. This cell line bound SV inefficiently and exhibited delayed
virus replication. Because cell surface heparan sulfate is an important
attachment molecule for SV (5, 22) we analyzed CHO-18.4m
cells for the synthesis of sulfated glycosaminoglycans. The cells were
deficient in heparan sulfate, further confirming the importance of
heparan sulfate as an attachment molecule for SV in vitro. This
technique may be useful for identifying other cellular genes important
for virus replication.
Cell lines.
CHO cells expressing the Moloney murine leukemia
virus (Mo-MuLV) ecotropic receptor (CHO-22) were obtained from H. Earl
Ruley, Vanderbilt University (1, 16). This cell line was
derived from CHO-K1 cells and was used as the host cell for retrovirus infection. CHO-22 and BHK cells were grown in Dulbecco's modified Eagle medium (DMEM) (GIBCO, Grand Island, N.Y.) supplemented with 10%
fetal bovine serum (FBS) (GIBCO).
Viruses.
Three strains of SV were used. AR339 was obtained
from the American Type Culture Collection (Manassas, Va.). NSV, a
neuroadapted strain of SV, was derived by serial passage of SV AR339 in
mouse brain (12). HRSP, a heat-resistant small-plaque strain
of AR339, was derived from serial passages of the HR strain in chicken
embryo fibroblasts (4). These viruses were plaque purified,
stocks were grown, and titers were determined by plaque formation under agar in BHK-21 cells.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characterization of a Chinese Hamster Ovary Cell Line
Developed by Retroviral Insertional Mutagenesis That Is Resistant
to Sindbis Virus Infection

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
85 virus producer cells (6). This virus has the neomycin resistance gene inserted into the U3 region. Expression of the neomycin resistance gene is dependent on insertion into transcriptionally active cellular promoters (42). For
each experiment, fresh producer cell supernatant fluid, passed through a 0.2-µm-pore-size filter, was used as a virus stock. The Mo-MuLV titer was estimated from the number of G418-resistant colonies arising
after infection of CHO-22 cells with serial dilutions of virus stocks.
Mo-MuLV infection and selection for provirus-containing, SV-resistant CHO clones. CHO-22 cells (106) were seeded on 100-mm dishes and the next day were incubated for 2 h with fresh U3Neo Mo-MuLV virus stock at a multiplicity of infection (MOI) of 0.01 in 0.5 ml of a medium containing 8 µg of Polybrene (16) per ml. The medium was removed, and 10 ml of the complete medium was added. One to 2 days later, selection was begun in a medium containing G418 (1 mg/ml) (Mediatech, Inc., Herndon, Va.). Seven to 10 days after the initiation of G418 selection, the second phase of selection was begun by infecting surviving cells with HRSP at an MOI of 5. Five to 7 days later, SV-resistant colonies were picked from the plates by using cloning rings and trypsinization. Individual plates contained 0 to 10 SV-resistant colonies and, to avoid sibling clones, only one colony was generally picked per dish. Cell clones were further expanded in 24-well plates. Some of these clones later died.
Molecular identification of the retroviral integration.
Genomic DNA from mutant CHO-18.4m cells was digested with
HindIII, separated by agarose gel electrophoresis, and
transferred to a prehybridized Hybond N+ charged nylon
membrane (Amersham, Arlington Heights, Ill.). Hybridization was done
with an [
-32P]dCTP-labeled
PstI-NcoI 387-bp fragment (from pOP13CAT;
Stratagene, La Jolla, Calif.) encompassing the 5' long terminal repeat
of Mo-MuLV. The membrane was incubated overnight at 65°C, washed in
2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) (pH
7.0)-0.1% (wt/vol) sodium dodecyl sulfate (SDS) at room temperature and then in 1× SSC-0.1% SDS at 65°C for 20 min. For
autoradiography, film was exposed for at least 2 days at
70°C.
Radiolabeling and purification of virions.
BHK-21 cells were
inoculated with SV at an MOI of 1 in DMEM (2% FBS), and 1 h later
the virus inoculum was removed and the cells were fed with methionine-
and cysteine-free MEM containing 10 µCi of
[35S]methionine-cysteine (Trans-label; ICN, Costa Mesa,
Calif.) per ml. When more than a 90% cytopathic effect was evident,
the supernatant fluid was harvested and clarified. Virus was
precipitated in 10% (wt/vol) polyethylene glycol 8000 in 0.5 M NaCl
for 2 to 3 h at 4°C and centrifuged at 10,000 × g for 1 h. Pelleted virus was resuspended in NET buffer
(10 mM Tris, 3 mM EDTA, 150 mM NaCl [pH 7.4]) and banded in a
continuous gradient of 15 to 40% potassium tartrate in
phosphate-buffered saline (pH 7.4) at 132,000 × g for
3 h. Banded virus was dialyzed against 0.05 M Tris-Cl (pH 7.4) at
4°C and stored in aliquots at
70°C.
Virus binding assays. These assays were performed as previously described (39). Briefly, radiolabeled virus (4,000 cpm per well) diluted in 0.4 ml of a cold binding medium (RPMI 1640 without NaHCO3, 0.2% bovine serum albumin, 20 mM HEPES) was added to confluent cells at 4°C. The supernatant and wash fluids were collected from triplicate wells to determine the level of unbound virus. Cells were dissolved in 1% SDS to determine the level of bound virus. The radioactivity in each fraction was counted.
Radioactive amino acid labeling for cellular protein synthesis. Confluent cells in 25-cm2 culture flasks were infected with SV at an MOI of 15. At various times after infection, 2 ml of a medium containing [35S]methionine-cysteine (50 µCi/ml) was added for 1 h. Cells were then washed with phosphate-buffered saline and lysed with radioimmunoprecipitation assay buffer (50 mM Tris-Cl [pH 7.5], 150 mM NaCl, 10 µM EDTA, 0.1% SDS, 1% Triton X-100, 1% deoxycholate). Equal amounts of cell lysates were analyzed on an SDS-15% polyacrylamide gel.
Infectious-center assay. CHO cells (106) were infected with SV at an MOI of 1 (titers determined in BHK-21 cells) for 2 h at 37°C. Cells were then washed six times with a cold medium to remove virus that had not been internalized and trypsinized. Suspended cells were washed three times with the medium, diluted, and placed onto a confluent monolayer of BHK-21 cells in six-well plates. After incubation for 1 h at 37°C, 0.6% agar in MEM containing 2% FBS was added. Plaques were counted 48 h after incubation.
Assessment of cell surface GAGs.
Cells were treated with 6 mIU of heparinase I (EC 4.2.2.7) (Sigma Chemical Co., St. Louis, Mo.)
per ml for 1 h at room temperature as previously described
(5), and the effect on virus binding was assessed. The
amount of cell surface heparan sulfate and chondroitin sulfate was
assayed quantitatively by labeling cells with
35SO42
and precipitating
glycosaminoglycans (GAGs) with cetylpyridinium chloride (CPC)
(7). Sixty-millimeter-diameter dishes containing 106 cells were labeled for 24 h in 5 ml of
sulfate-free DMEM containing 10% dialyzed FBS, 100 U of penicillin per
ml, and 50 µCi of 35SO42
(New
England Nuclear, Beverly, Mass.). Cells were lysed with 0.1 N NaOH,
exhaustively digested with pronase, and precipitated with 1.25% CPC
according to the protocol of J. D. Esko (7). Chondroitin sulfate A at a concentration of 4 mg/ml was included as a
carrier. GAGs were treated with 200 mIU of chondroitinase ABC (Sigma)
or mock treated and then reprecipitated with CPC containing a carrier
GAG, and radioactivity was counted by liquid scintillation. Counts were
normalized to the protein concentration of the original cell lysate, as
determined by the Bradford assay (Bio-Rad, Hercules, Calif.) with
bovine serum albumin as a standard.
| |
RESULTS |
|---|
|
|
|---|
Generation of SV-resistant CHO mutant cells by retroviral insertional mutagenesis. CHO-22 cells were infected with U3Neo Mo-MuLV and selected first with G418 and then with the HRSP strain of SV. Although the U3Neo vector is inserted randomly, only those insertions which juxtapose the neomycin resistance gene and a cellular promoter will result in G418 resistance, since the U3 promoter is disrupted in this virus (3, 20, 31, 34, 42).
In principle, because a mammalian cell expresses only 10,000 to 20,000 genes, a library of 2 × 105 Neor cell clones should be enough to disrupt all readily targeted genes. We screened more than 2 × 106 Neor cell clones by HRSP infection. Approximately 1 in 1,000 G418-resistant colonies survived infection with HRSP. Approximately two-thirds of these colonies died thereafter, usually associated with productive virus replication. Finally, a total of 76 resistant clones were obtained. These mutant clones were then tested to confirm their resistance to HRSP infection. Different levels of resistance, as judged by viability (Fig. 1A) and virus production (Fig. 1B), were evident. Among these clones, CHO-18.4m was the most resistant to HRSP infection and was selected for further studies.
|
Characterization of the resistance of CHO-18.4m cells to SV
infection.
CHO-18.4m cells showed no visible plaques under agar
after infection by HRSP while the expected small plaques (about 1 to 2 mm in diameter) were obtained in the parent CHO-22 cells (Table 1). There were no significant differences
in plaque size after infection with the more neurovirulent AR339 and
NSV strains of SV (12, 25), but CHO-18.4m cells were less
susceptible to infection since the number of plaques formed was 5- to
10-fold lower than the number formed in CHO-22 cells (Table 1). The
CHO-18.4m cells survived longer after infection (Fig.
2A), and the growth of HRSP in CHO-18.4m
cells was delayed by 24 h compared to growth in CHO-22 cells (Fig.
2B).
|
|
|
|
Infectious-center assay of HRSP-infected CHO-18.4m and CHO-22 cells. We further analyzed the comparative efficiencies of SV infection of CHO-18.4m and CHO-22 cells by an infectious-center assay, which assesses productive infection of individual cells. After 2 h of incubation with HRSP at an MOI (as determined in BHK cells) of 1, 106 cells from each CHO cell clone were analyzed for their ability to initiate infection when overlaid on BHK cells. Only 1.2 × 102 CHO-18.4m cells (0.012%) were scored as infectious, whereas 2 × 104 CHO-22 cells (2%) were scored as infectious. The ratio of infectious CHO-22 cells to infectious CHO-18.4m cells was therefore approximately 100:1, a difference that is larger than that found in virus binding.
Analysis of retroviral insertion in CHO-18.4m cells. To determine the number of retroviral integrations into the cellular genomes of CHO-18.4m cells, DNA isolated from CHO-18.4m and CHO-22 cells was digested with HindIII and subjected to Southern blot analysis with the neomycin resistance gene probe (Fig. 5). A band of 7.2 kb was seen in CHO-18.4m DNA but not in CHO-22 DNA. Therefore, only one copy of the retroviral vector was inserted into CHO-18.4m cells, consistent with the disruption of a single gene.
|
Analysis of the presence of GAGs on the cell surface. Since heparan sulfate was recently identified as an important initial cell surface binding element for SV (5, 22) and CHO-18.4m cells had a defect in virus binding, cells were analyzed to determine whether CHO-18.4m cells might be deficient in GAGs (Fig. 6). The pretreatment of cells with heparinase significantly decreased the binding of SV to CHO-22 cells but did not affect SV binding to CHO-18.4m cells, indicating that CHO-18.4m cells lack heparan sulfate.
|
3.27 ± 0.54 and 1,167.3 ± 413.4 cpm per µg of
protein for CHO-18.4m and CHO-22 cells, respectively).
| |
DISCUSSION |
|---|
|
|
|---|
SV infects most vertebrate cell lines and causes apoptosis. Cells have different susceptibilities to SV infection and to SV-induced apoptosis depending on cell type and maturity both in vivo and in vitro. Cellular factors are therefore important in influencing the process of virus infection. For example, BHK cells are killed faster and produce a higher titer of virus than CHO cells. A mosquito cell line, C6/36, is not killed by AR339; however, this virus induces cell death in most vertebrate cell lines. The retroviral gene trap is a useful tool to generate cell mutants expressing altered phenotypes and to pinpoint the genomic loci associated with these mutant phenotypes. We have shown that cells resistant to SV infection can be developed by retroviral insertional mutagenesis. The mutant cells isolated were shown to lack heparan sulfate, a cell surface GAG that is responsible for the initial binding of SV to the surfaces of cells in culture (5, 22).
Using the retroviral gene trap approach to selecting cells resistant to SV infection produced 76 mutant CHO cell clones. However, none of these clones was completely resistant to HRSP, indicating that SV replication involves many cellular genes and that those that are essential for virus replication may also be essential for cell survival. Partial resistance to SV infection has also been a characteristic of CHO cells selected after chemical mutagenesis (27, 28). We assume that the viral selection of mutant cells was successful, despite the fact that resistance to HRSP-induced apoptosis was not complete, because the efficiency of infection of the mutant cells was markedly reduced. During the initial selection there were on average fewer than 10 cell colonies surviving in a 100-mm-diameter culture plate. Any virus produced became diluted in the overlying medium. The cellular mutations selected led to inefficient infection, which is most apparent when the MOI is low. This may be the reason that many of the cell clones died after they were propagated and thus were exposed to more concentrated virus.
The CHO-18.4m cell line was the most resistant to HRSP infection and showed a deficiency in virus binding. Southern blot analysis showed that only one copy of the retroviral vector was inserted into cellular DNA. The cellular gene disrupted was therefore likely to be involved in the expression of a molecule that participates in virus binding. We chose the gene trap approach to mutagenesis to enhance our ability to identify cellular genes important for SV replication. However, we were able to sequence only 9 bp of the flanking sequence, which was insufficient to identify the cellular gene disrupted (data not shown), and therefore we turned to the candidate gene approach based on our previous studies of molecules important for SV binding to CHO cells (5) to identify the cellular defect.
Several attempts have been made to identify a SV receptor(s). The first studies were reported by Smith and Tignor (33), who showed that the receptor for SV on neuroblastoma cells is a protein that binds neurovirulent SV better than avirulent SV. Particular molecules that have been suggested include a 90-kDa surface protein on human lymphoblastoid cells (26), the high-affinity laminin receptor (67 kDa) on BHK-21 cells (43), and a 74-kDa glycoprotein on N18 mouse neuroblastoma cells (41). Most recently, some of this confusion may have been resolved by the identification of heparan sulfate as important for the initial attachment of SV to cells in tissue culture (5, 22). It is possible that some of these putative receptors are heparan sulfate-bearing proteoglycans.
Mutant cell lines which escape killing by other viruses have been reported, and a variety of mechanisms for resistance have been identified. Mutant cell lines resistant to herpes simplex virus killing have mutations in surface proteoglycan synthesis, rendering them resistant to virus attachment and entry (2, 13). In other cases, defects of postentry processing and progeny virus maturation have been identified (17, 40, 44). Previously described CHO cells resistant to SV infection show defects in endosomal acidification required for virus entry (28), in furin required for processing PE2 to E2 (44), and in virus binding (27). Our CHO-18.4m cells were deficient in cell surface heparan sulfate and appear to be resistant to SV infection by a mechanism similar to that found for herpes simplex virus (32). We assume that, as for herpes simplex virus (29, 37), there are additional surface molecules that mediate SV entry into cells but that these surface molecules are less effective for initial virus binding and thus, when expressed alone, initiate infection inefficiently.
Cellular receptors have a critical role in virus-cell interaction and the spread of infection. The receptors for some viruses participate both in initial virus binding and also in virus entry. For instance, domains 1 and 2 of intercellular adhesion molecule 1, the receptor for most rhinoviruses, bind the virus, and domains 3 and 4 mediate penetration and uncoating (10). However, for many viruses penetration is mediated through molecules other than the original attachment molecule. For instance, CD4 is the initial binding protein for HIV, but entry is dependent on subsequent binding to a member of the G-protein coupled chemokine receptor family (8).
Strains of SV differ in virulence, and this is often correlated with the efficiency of binding to neural cells (38). AR339 causes fatal encephalitis in young mice, while NSV, one of the most virulent strains of SV, kills both young and adult mice. HRSP, which forms small plaques in cell monolayers, is the least virulent strain and does not reproducibly kill newborn mice (25). HRSP, AR339, and NSV showed a similar order of virulence in both CHO-18.4m and CHO-22 cells. The same virus inoculum produced different numbers of plaques in different cell lines, indicating differences in the efficiency of infection. For example, an HRSP inoculum that formed 108 plaques in BHK-21 cells formed only 106 to 107 plaques in CHO-22 cells. Successful infection is therefore determined by both the virus infectivity and the cell susceptibility. Further studies will be required to identify the specific gene disrupted and to identify the secondary receptor used efficiently by NSV to infect CHO-18.4m cells lacking heparan sulfate.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jeffrey Esko for helpful discussions.
This work was supported by Public Health Service grant NS18596 (D.E.G.), a postdoctoral fellowship from the National Multiple Sclerosis Society (A.P.B.), and a predoctoral scholarship from the Taiwan National Defense Medical Center (J.-T.J.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, 615 N. Wolfe St., Rm. E5132, Baltimore, MD 21205. Phone: (410) 955-3459. Fax: (410) 955-0105. E-mail: dgriffin{at}jhsph.edu.
Present address: National Defense Medical Center, Institute of
Preventive Medicine, Taipei, Taiwan, Republic of China.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Albritton, L. M., L. Tseng, D. T. Scadden, and J. M. Cunningham. 1989. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666[Medline]. |
| 2. | Banfield, B. W., Y. Leduc, L. Esford, K. Schubert, and F. Tufaro. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:3290-3298[Abstract]. |
| 3. | Barklis, E., R. C. Mulligan, and R. Jaenisch. 1986. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399[Medline]. |
| 4. | Burge, B., and E. Pfefferkorn. 1966. Isolation and characterization of conditional lethal mutants of Sindbis virus. Virology 30:204-213[Medline]. |
| 5. |
Byrnes, A. P., and D. E. Griffin.
1998.
Binding of Sindbis virus to cell surface heparan sulfate.
J. Virol.
72:7349-7356 |
| 6. | Chang, W., C. Hubbard, C. Friedel, and H. E. Ruley. 1993. Enrichment of insertional mutants following retrovirus gene trap selection. Virology 193:737-747[Medline]. |
| 7. | Esko, J. D. 1993. Preparation and analysis of glycoconjugates, p. 1721-1729. In Current protocols in molecular biology. Wiley, New York, N.Y. |
| 8. | Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-876[Abstract]. |
| 9. | Frankel, W., T. A. Potter, N. Rosenberg, J. Lenz, and T. V. Rajan. 1995. Retroviral insertional mutagenesis of a target allele in a heterozygous murine cell line. Proc. Natl. Acad. Sci. USA 82:6600-6604. |
| 10. |
Greve, J. M.,
C. P. Forte,
C. W. Marlor,
A. M. Meyer,
H. Hoover-Litty,
D. Wunderlich, and A. McClelland.
1991.
Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.
J. Virol.
65:6015-6023 |
| 11. | Griffin, D. E., and J. M. Hardwick. 1997. Regulators of apoptosis on the road to persistent alphavirus infection. Annu. Rev. Microbiol. 51:565-592[Medline]. |
| 12. |
Griffin, D. E., and R. T. Johnson.
1977.
Role of the immune response in recovery from Sindbis virus encephalitis in mice.
J. Immunol.
118:1070-1075 |
| 13. |
Gruenheid, S.,
L. Gatzke,
H. Meadows, and F. Tufaro.
1993.
Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans.
J. Virol.
67:93-100 |
| 14. | Gupta, R. S., D. Y. Chan, and L. Siminovitch. 1978. Evidence for functional hemizygosity at the Emtr locus in CHO cells through segregation analysis. Cell 14:1007-1013[Medline]. |
| 15. | Gupta, R. S., D. Y. Chan, and L. Siminovitch. 1978. Evidence for variation in the number of functional gene copies at the AmaR locus in Chinese hamster cell lines. J. Cell. Physiol. 97:461-467[Medline]. |
| 16. |
Hubbard, S. C.,
L. Walls,
H. E. Ruley, and E. A. Muchmore.
1994.
Generation of Chinese hamster ovary cell glycosylation mutants by retroviral insertional mutagenesis.
J. Biol. Chem.
269:3717-3724 |
| 17. |
Inocencio, N. M.,
J. M. Moehring, and T. J. Moehring.
1993.
A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A is unable to process the precursor fusion glycoprotein of Newcastle disease virus.
J. Virol.
67:593-595 |
| 18. | Jackson, A. C., T. R. Moench, and D. E. Griffin. 1987. The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab. Investig. 56:418-423[Medline]. |
| 19. | Jackson, A. C., T. R. Moench, B. D. Trapp, and D. E. Griffin. 1988. Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab. Investig. 58:503-509[Medline]. |
| 20. | Jaenisch, R., D. Jahner, P. Nobis, I. Simon, J. Lohler, K. Harbers, and D. Grotkopp. 1981. Chromosomal position and activation of retroviral genomes inserted into the germ line of mice. Cell 24:519-529[Medline]. |
| 21. |
King, W.,
M. D. Patel,
L. I. Lobel,
S. P. Goff, and M. C. Nguyen-Huu.
1985.
Insertion mutagenesis of embryonal carcinoma cells by retroviruses.
Science
228:554-558 |
| 22. |
Klimstra, W. B.,
K. D. Ryman, and R. E. Johnston.
1998.
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.
J. Virol.
72:7357-7366 |
| 23. | Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739-742[Medline]. |
| 24. | Lewis, J., S. L. Wesselingh, D. E. Griffin, and J. M. Hardwick. 1996. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1828-1835[Abstract]. |
| 25. |
Lustig, S.,
A. C. Jackson,
C. S. Hahn,
D. E. Griffin,
E. G. Strauss, and J. H. Strauss.
1988.
The molecular basis of Sindbis virus neurovirulence in mice.
J. Virol.
62:2329-2336 |
| 26. | Maassen, J. A., and C. Terhorst. 1981. Identification of a cell-surface protein involved in the binding site of Sindbis virus on human lymphoblastoic cell lines using a heterobifunctional cross-linker. Eur. J. Biochem. 115:153-158[Medline]. |
| 27. | Mento, S. J., and L. Siminovitch. 1981. Isolation and preliminary characterization of Sindbis virus-resistant Chinese hamster ovary cells. Virology 111:320-330[Medline]. |
| 28. |
Moehring, J. M., and T. J. Moehring.
1983.
Strains of CHO-K1 cells resistant to Pseudomonas exotoxin A and cross-resistant to diphtheria toxin and viruses.
Infect. Immun.
41:998-1009 |
| 29. | Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436[Medline]. |
| 30. | Niklasson, B., A. Espmark, J. W. LeDuc, T. P. Gargan, W. A. Ennis, R. B. Tesh, and A. J. Main, Jr. 1984. Association of a Sindbis-like virus with Ockelbo disease in Sweden. Am. J. Trop. Med. Hyg. 33:1212-1217. |
| 31. |
Reddy, S.,
J. V. DeGregori,
H. von Melchner, and H. E. Ruley.
1991.
Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells.
J. Virol.
65:1507-1515 |
| 32. |
Shieh, M. T.,
D. WuDunn,
R. I. Montgomery,
J. D. Esko, and P. G. Spear.
1992.
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.
J. Cell Biol.
116:1273-1281 |
| 33. | Smith, A. L., and G. H. Tignor. 1980. Host receptors for two strains of Sindbis virus. Arch. Virol. 66:11-26[Medline]. |
| 34. |
Sorge, J.,
A. E. Cutting,
V. D. Erdman, and J. W. Gautsch.
1984.
Integration-specific retrovirus expression in embryonal carcinoma cells.
Proc. Natl. Acad. Sci. USA
81:6627-6631 |
| 35. |
Stanley, P., and W. Chaney.
1985.
Control of carbohydrate processing: the lec1A CHO mutation results in partial loss of N-acetylglucosaminyltransferase I activity.
Mol. Cell. Biol.
5:1204-1211 |
| 36. |
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562 |
| 37. |
Terry-Allison, T.,
R. I. Montgomery,
J. C. Whitbeck,
R. Xu,
G. H. Cohen, and R. J. Eisenberg.
1998.
HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion.
J. Virol.
72:5802-5810 |
| 38. |
Tucker, P. C., and D. E. Griffin.
1991.
The mechanism of altered Sindbis virus neurovirulence associated with a single amino acid change in the E2 glycoprotein.
J. Virol.
65:1551-1557 |
| 39. | Tucker, P. C., S. H. Lee, N. Bui, D. Martinie, and D. E. Griffin. 1997. Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells. J. Virol. 71:6106-6112[Abstract]. |
| 40. |
Tufaro, F.,
M. D. Snider, and S. L. McKnight.
1987.
Identification and characterization of a mouse cell mutant defective in the intracellular transport of glycoproteins.
J. Cell Biol.
105:647-657 |
| 41. |
Ubol, S., and D. E. Griffin.
1991.
Identification of a putative alphavirus receptor on mouse neural cells.
J. Virol.
65:6913-6921 |
| 42. |
von Melchner, H., and H. E. Ruley.
1989.
Identification of cellular promoters by using a retrovirus promoter trap.
J. Virol.
63:3227-3233 |
| 43. |
Wang, K.-S.,
R. J. Kuhn,
E. G. Strauss,
S. Ou, and J. H. Strauss.
1992.
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells.
J. Virol.
66:4992-5001 |
| 44. |
Watson, D. G.,
J. M. Moehring, and T. J. Moehring.
1991.
A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A and alphaviruses fails to cleave Sindbis virus gycoprotein PE2.
J. Virol.
65:2332-2339 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»